A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics

Annals of Biomedical Engineering

Volumn 42, Issue 2, 2014, Pages 280-298

  Qin, Shengping ^a   Fite, Brett Z ^a   Gagnon, M Karen J ^a   Seo, Jai W ^a   Curry, Fitz Roy ^b   Thorsen, Frits ^c   Ferrara, Katherine W ^a  

^a University of California Davis   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Delivery of therapeutics; Nanotherapeutic constructs; Pharmacokinetics; Quantitative imaging

Indexed keywords

BLOOD VESSELS; DISEASES; LIPOSOMES; MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; ULTRASONIC APPLICATIONS; ULTRASONICS;

APPARENT PERMEABILITIES; DELIVERY OF THERAPEUTICS; INTRACELLULAR TRAFFICKING; NANOTHERAPEUTIC CONSTRUCTS; POSITRON EMISSION TOMOGRAPHY (PET); QUANTITATIVE COMPARISON; QUANTITATIVE IMAGING; QUANTITATIVE MEASUREMENT;

OPTIMIZATION;

ALBUMIN; BENZOIC ACID; CHELATING AGENT; CISPLATIN; CONTRAST MEDIUM; DOXORUBICIN; FERUCARBOTRAN; GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; GADOTERIDOL; GALLIUM 67; LIPOSOME; MONOCLONAL ANTIBODY; NANOPARTICLE; PACLITAXEL; PEPTIDE; PROTEIN; RADIOISOTOPE; TRACER; ZIRCONIUM;

BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; BODY SURFACE; BREAST CANCER; CANCER DIAGNOSIS; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; EXTRAVASATION; IMAGING; INTERNALIZATION; ISOTOPE LABELING; METHODOLOGY; MOLECULAR IMAGING; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; POSITRON EMISSION TOMOGRAPHY; PRECANCER; PRIORITY JOURNAL; SOLUTE; TARGET CELL; TARGET ORGAN; TEMPERATURE SENSITIVITY; ULTRASOUND;

ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; ULTRASONOGRAPHY;

EID: 84899419834     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-013-0895-2     Document Type: Conference Paper

References (136)

1. 89Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer. Pharm. Res. 30:878-888, 2013.
2. Ahmad, M. Z., S. Akhter, Z. Rahman, S. Akhter, M. Anwar, N. Mallik, and F. J. Ahmad. Nanometric gold in cancer nanotechnology: current status and future prospect. J. Pharm. Pharmacol. 65:634-651, 2013.
3. Ahmed, M., W. E. Monsky, G. Girnun, A. Lukyanov, G. D'Ippolito, J. B. Kruskal, K. E. Stuart, V. P. Torchilin, and S. N. Goldberg. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res. 63:6327-6333, 2003.
4. Alkilany, A. M., S. E. Lohse, and C. J. Murphy. The gold standard: gold nanoparticle libraries to understand the nano-bio interface. Acc. Chem. Res. 46:650-661, 2013.
5. Alkins, R., A. Burgess, M. Ganguly, G. Francia, R. Kerbel, W. S. Wels, and K. Hynynen. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 73:1892-1899, 2013.
6. 99mTc-liposomes. Investig. Radiol. 37:435-439, 2002.
7. Awasthi, V., B. Goins, R. Klipper, R. Loredo, D. Korvick, and W. T. Phillips. Imaging experimental osteomyelitis using radiolabeled liposomes. J. Nucl. Med. 39:1089-1094, 1998.
8. Bale, R., and G. Widmann. Navigated CT-guided interventions. Minim. Invasive Ther. Allied Technol. 16:196-204, 2007.
9. 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation. J. Pharm. Sci. 92:1893-1904, 2003.
10. Barentsz, J. O., O. Berger-Hartog, J. A. Witjes, C. Hulsbergen-van Der Kaa, G. O. N. Oosterhof, J. A. W. M. Vander Laak, H. Kondacki, and S. H. J. Ruijs. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 207:791-797, 1998.
11. Bhattacharyya, S., K. Kurdziel, L. Wei, L. Riffle, G. Kaur, G. C. Hill, P. M. Jacobs, J. L. Tatum, J. H. Doroshow, and J. D. Kalen. Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas. Nucl. Med. Biol. 40:451-457, 2013.
12. * relaxivities of human whole blood to ProHance, vasovist, and deoxyhemoglobin. Magn. Reson. Med. 60:1313-1320, 2008.
13. Boellaard, R. Standards for PET image acquisition and quantitative data analysis. J. Nucl. Med. 50:11s-20s, 2009.
14. Brix, G., W. Semmler, R. Port, L. R. Schad, G. Layer, and W. J. Lorenz. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J. Comput. Assist. Tomogr. 15:621-628, 1991.
15. 89Zr-labeled panitumumab for immuno-positron emission tomographic imaging of the epidermal growth factor receptor. Mol. Imaging 12:17-27, 2013.
16. Chen, X., K. J. Barkauskas, B. D. Weinberg, J. L. Duerk, F. W. Abdul-Karim, S. Paul, and G. M. Saidel. Dynamics of MRI-guided thermal ablation of VX2 tumor in paraspinal muscle of rabbits. IEEE Trans. Biomed. Eng. 55:1004-1014, 2008.
17. Cho, H., T. C. Lai, and G. S. Kwon. Poly (ethylene glycol) - block-poly (epsilon-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer. J. Controlled Release 166:1-9, 2013.
18. Cline, H. E., K. Hynynen, C. J. Hardy, R. D. Watkins, J. F. Schenck, and F. A. Jolesz. MR temperature mapping of focused ultrasound surgery. Magn. Reson. Med. 31:628-636, 1994.
19. Curry, F. R. E., C. B. Rygh, T. Karlsen, H. Wiig, R. H. Adamson, J. F. Clark, Y. C. Lin, B. Gassner, F. Thorsen, I. Moen, O. Tenstad, M. Kuhn, and R. K. Reed. Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume. J. Physiol. Lond. 588:325-339, 2010.
20. 99mTc-PEG liposomes and 99mTc-HYNIC IgG. Ann. Surg. 229:551-557, 1999.
21. Daniel, M. C., and D. Astruc. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104:293-346, 2004.
22. Delli Castelli, D., W. Dastru, E. Terreno, E. Cittadino, F. Mainini, E. Torres, M. Spadaro, and S. Aime. In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes. J. Controlled Release 144:271-279, 2010.
23. 89Zr: from radiochemistry to the clinic. Nucl. Med. Biol. 40:3-14, 2013.
24. Desale, S. S., S. M. Cohen, Y. Zhao, A. V. Kabanov, and T. K. Bronich. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer. J. Controlled Release 2013, in press.
25. Devoogdt, N., C. Xavier, S. Hernot, I. Vaneycken, M. D'Huyvetter, J. De Vos, S. Massa, P. De Baetselier, V. Caveliers, and T. Lahoutte. Molecular imaging using Nanobodies: a case study. Methods Mol. Biol. (Clifton, NJ) 911:559-567, 2012.
26. Dewhirst, M. W., Z. Vujaskovic, E. Jones, and D. Thrall. Re-setting the biologic rationale for thermal therapy. Int. J. Hyperth. 21:779-790, 2005.
27. Dong, H., N. Dube, J. Y. Shu, J. W. Seo, L. M. Mahakian, K. W. Ferrara, and T. Xu. Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates. ACS Nano 6:5320-5329, 2012.
28. Dreher, M. R., W. G. Liu, C. R. Michelich, M. W. Dewhirst, F. Yuan, and A. Chilkoti. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J. Natl. Cancer Inst. 98:335-344, 2006.
29. Epenetos, A. A., D. Snook, H. Durbin, P. M. Johnson, and J. Taylor-Papadimitriou. Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res. 46:3183-3191, 1986.
30. Erlemann, R., M. F. Reiser, P. E. Peters, P. Vasallo, B. Nommensen, C. R. Kusnierzglaz, J. Ritter, and A. Roessner. Musculoskeletal neoplasms-static and dynamic Gd-DTPA Enhanced MR imaging. Radiology 171:767-773, 1989.
31. Erlemann, R., J. Sciuk, A. Bosse, J. Ritter, C. R. Kusnierzglaz, P. E. Peters, and P. Wuisman. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy-assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 175:791-796, 1990.
32. Fite, B. Z., Y. Liu, D. E. Kruse, C. F. Caskey, J. H. Walton, C. Y. Lai, L. M. Mahakian, B. Larrat, E. Dumont, and K. W. Ferrara. Magnetic resonance thermometry at 7T for real-time monitoring and correction of ultrasound induced mild hyperthermia. PLoS ONE 7:e35509, 2012.
33. Frenkel, V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv. Drug Deliv. Rev. 60:1193-1208, 2008.
34. Fry, F. J., H. W. Ades, and W. J. Fry. Production of reversible changes in the central nervous system by ultrasound. Science 127:83-84, 1958.
35. Fry, W. J., and F. Dunn. Ultrasonic irradiation of the central nervous system at high sound levels. J. Acoust. Soc. Am. 28:129-131, 1956.
36. Fry, W. J., V. J. Wulff, D. Tucker, and F. J. Fry. Physical factors involved in ultrasonically induced changes in living systems: identification of non-temperature effects. J. Acoust. Soc. Am. 22:867-876, 1950.
37. Gaber, M. H., N. Z. Wu, K. Hong, S. K. Huang, M. W. Dewhirst, and D. Papahadjopoulos. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int. J. Radiat. Oncol. Biol. Phys. 36:1177-1187, 1996.
38. Gabizon, A., D. C. Price, J. Huberty, R. S. Bresalier, and D. Papahadjopoulos. Effect of Liposome composition and other factors on the targeting of liposomes to experimental-tumors-biodistribution and imaging studies. Cancer Res. 50:6371-6378, 1990.
39. Gabizon, A., H. Shmeeda, and Y. Barenholz. Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clin. Pharmacokinet. 42:419-436, 2003.
40. Gagnon, M. K. J., S. H. Hausner, J. Marik, C. K. Abbey, J. F. Marshall, and J. L. Sutcliffe. High-throughput in vivo screening of targeted molecular imaging agents. Proc. Natl. Acad. Sci. 106:17904-17909, 2009.
41. Goldberg, S. N., and M. Ahmed. Minimally invasive image-guided therapies for hepatocellular carcinoma. J. Clin. Gastroenterol. 35:S115-S129, 2002.
42. Gore, J. C., H. C. Manning, C. C. Quarles, K. W. Waddell, and T. E. Yankeelov. Magnetic resonance in the era of molecular imaging of cancer. Magn. Reson. Imaging 29:587-600, 2011.
43. 18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin alphavbeta6. J. Nucl. Med. 54:1101-1105, 2013.
44. Hajitou, A., R. Pasqualini, and W. Arap. Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc. Med. 16:80-88, 2006.
45. 18F]fluorine by copper-free, strainpromoted click chemistry. Nucl. Med. Biol. 40:233-239, 2013.
46. Hawighorst, H., P. G. Knapstein, U. Schaeffer, M. V. Knopp, G. Brix, U. Hoffman, I. Zuna, M. Essig, and G. Van Kaick. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. Am. J. Roentgenol. 166:401-408, 1996.
47. Hawighorst, H., P. G. Knapstein, W. Weikel, M. V. Knopp, I. Zuna, A. Knof, G. Brix, U. Schaeffer, C. Wilkens, S. O. Schoenberg, M. Essig, P. Vaupel, and G. Van Kaick. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res. 57:4777-4786, 1997.
48. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. J. Nucl. Med. 51:1293-1300, 2010.
49. Howseman, A. M., and R. W. Bowtell. Functional magnetic resonance imaging: imaging techniques and contrast mechanisms. Philos. Trans. R. Soc. B 354:1179-1194, 1999.
50. Hulka, C. A., B. L. Smith, D. C. Sgroi, L. J. Tan, W. B. Edmister, J. P. Semple, T. Campbell, D. B. Kopans, T. J. Brady, and R. M. Weisskoff. Benign and malignant breast-lesions-differentiation with echo-planar MR-imaging. Radiology 197:33-38, 1995.
51. Hynynen, K., A. Darkazanli, E. Unger, and J. F. Schenck. MRI-Guided noninvasive ultrasound surgery. Med. Phys. 20:107-115, 1993.
52. 89Zr-RGD peptides. Mol. Imaging Biol. 13:1224-1233, 2011.
53. Johnson, R. P., Y. I. Jeong, J. V. John, C. W. Chung, D. H. Kang, M. Selvaraj, H. Suh, and I. Kim. Dual stimuliresponsive poly (N-isopropylacrylamide)-b-poly (L-histidine) chimeric materials for the controlled delivery of doxorubicin into liver carcinoma. Biomacromolecules 14:1434-1443, 2013.
54. Jones, E. L., J. R. Oleson, L. R. Prosnitz, T. V. Samulski, Z. Vujaskovic, D. H. Yu, L. L. Sanders, and M. W. Dewhirst. Randomized trial of hyperthermia and radiation for superficial tumors. J. Clin. Oncol. 23:3079-3085, 2005.
55. Judenhofer, M. S., and S. R. Cherry. Applications for preclinical PET/MRI. Semin. Nucl. Med. 43:19-29, 2013.
56. Key, J., C. Cooper, A. Y. Kim, D. Dhawan, D. W. Knapp, K. Kim, J. H. Park, K. Choi, I. C. Kwon, K. Park, and J. F. Leary. In vivo NIRF and MR dualmodality imaging using glycol chitosan nanoparticles. J. Controlled Release 163:249-255, 2012.
57. Kheirolomoom, A., D. E. Kruse, S. Qin, K. E. Watson, C.-Y. Lai, L. J. T. Young, R. D. Cardiff, and K. W. Ferrara. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J. Controlled Release 141:128-136, 2010.
58. Kim, S. M., M. A. Haider, M. Milosevic, and I. W. Yeung. A comparison of dynamic contrast-enhanced CT and MR imaging-derived measurements in patients with cervical cancer. Clin. Physiol. Funct. Imaging 33:150-161, 2013.
59. Klibanov, A. L., K. Maruyama, V. P. Torchilin, and L. Huang. Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235-237, 1990.
60. Knopp, M. V., N. Himmelhan, J. Radeleff, H. Junkermann, T. Hess, H. P. Sinn, and G. Brix. Comparison of quantification techniques for dynamic contrast enhancement MRI analyzed using MR mammography. Radiologe 42:280-290, 2002.
61. Langereis, S., J. Keupp, J. L. J. Van Velthoven, I. H. C. De Roos, D. Burdinski, J. A. Pikkemaat, and H. Gruell. A temperature-sensitive liposomal H-1 CEST and F-19 contrast agent for MR image-guided drug delivery. J. Am. Chem. Soc. 131:1380-1381, 2009.
62. 99mTc by the hydrazino nicotinyl derivative. J. Nucl. Med. 40:192-197, 1999.
63. Lee, S. Y., H. S. Park, K. Y. Lee, H. J. Kim, Y. J. Jeon, T. W. Jang, K. H. Lee, Y. C. Kim, K. S. Kim, I. J. Oh, and S. Y. Kim. Paclitaxel-loaded polymeric micelle (230 mg/m (2)) and cisplatin (60 mg/m (2)) vs. paclitaxel (175 mg/m (2)) and cisplatin (60 mg/m (2)) in advanced non-smallcell lung cancer: a multicenter randomized phase IIB trial. Clin. Lung Cancer 14:275-282, 2013.
64. Lencioni, R., and L. Crocetti. Image-guided thermal ablation of hepatocellular carcinoma. Crit. Rev. Oncol. Hematol. 66:200-207, 2008.
65. Liu, S., M. Hassink, R. Selvaraj, L. P. Yap, R. Park, H. Wang, X. Chen, J. M. Fox, Z. Li, and P. S. Conti. Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation. Mol. Imaging 12:121-128, 2013.
66. Liu, D., D. Overbey, L. D. Watkinson, C. J. Smith, S. Daibes-Figueroa, T. J. Hoffman, L. R. Forte, W. A. Volkert, and M. F. Giblin. Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer. Bioconjug. Chem. 21:1171-1176, 2010.
67. Logan, J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl. Med. Biol. 27:661-670, 2000.
68. Lynn, J. G., R. L. Zwemer, A. J. Chick, and A. E. Miller. A new method for the generation and use of focused ultrasound in experimental biology. J. Gen. Physiol. 26:179-193, 1942.
69. 18F]FDP). Nucl. Med. Biol. 34:165-171, 2007.
70. Meijs, W. E., J. D. Herscheid, H. J. Haisma, and H. M. Pinedo. Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89. Int. J. Radiat. Appl. Instrum. A 43:1443-1447, 1992.
71. Ng, T., J. R. Bading, R. Park, H. Sohi, D. Procissi, D. Colcher, P. S. Conti, S. R. Cherry, A. A. Raubitschek, and R. E. Jacobs. Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner. J. Nucl. Med. 53:1102-1109, 2012.
72. Niemeyer, C. M. Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science. Angew. Chem. Int. Edit. 40:4128-4158, 2001.
73. Ogihara, I., S. Kojima, and M. Jay. Differential uptake of gallium-67-labeled liposomes between tumors and inflammatory lesions in rats. J. Nucl. Med. 27:1300-1307, 1986.
74. Ogihara-Umeda, I., T. Sasaki, S. Kojima, and H. Nishigori. Optimal radiolabeled liposomes for tumor imaging. J. Nucl. Med. 37:326-332, 1996.
75. Ogihara-Umeda, I., T. Sasaki, H. Toyama, K. Oda, M. Senda, and H. Nishigori. Rapid diagnostic imaging of cancer using radiolabeled liposomes. Cancer Detect. Prev. 21:490-496, 1997.
76. Paoli, E. E., D. E. Kruse, J. W. Seo, H. Zhang, A. Kheirolomoom, K. D. Watson, P. Chiu, H. Stahlberg, and K. W. Ferrara. An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: importance of formulation. J. Controlled Release 143:13-22, 2010.
77. Parker, D. L. Applications of NMR imaging in hyperthermia-an evaluation of the potential for localized tissue heating and noninvasive temperature monitoring. IEEE Trans. Biomed. Eng. 31:161-167, 1984.
78. Parker, D. L., V. Smith, P. Sheldon, L. E. Crooks, and L. Fussell. Temperature distribution measurements in two-dimensional NMR imaging. Med. Phys. 10:321-325, 1983.
79. Perrault, S. D., C. Walkey, T. Jennings, H. C. Fischer, and W. C. W. Chan. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9:1909-1915, 2009.
80. 18F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts. Nucl. Med. Biol. 40:618-624, 2013.
81. Peters, R. D., R. S. Hinks, and R. M. Henkelman. Ex vivo tissue-type independence in proton-resonance frequency shift MR thermometry. Magn. Reson. Med. 40:454-459, 1998.
82. Phillips, W. T., A. S. Rudolph, B. Goins, J. H. Timmons, R. Klipper, and R. Blumhardt. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Int. J. Radiat. Appl. Instrum. 19:539-547, 1992.
83. Ponce, A. M., B. L. Viglianti, D. H. Yu, P. S. Yarmolenko, C. R. Michelich, J. Woo, M. B. Bally, and M. W. Dewhirst. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J. Natl Cancer Inst. 99:53-63, 2007.
84. Poon, J., M. Dahlbom, W. Moses, K. Balakrishnan, W. Wang, S. Cherry, and R. Badawi. Optimal whole-body PET scanner configurations for different volumes of LSO scintillator: a simulation study. Phys. Med. Biol. 57:4077, 2012.
85. Qin, S., J. W. Seo, H. Zhang, J. Qi, F. R. Curry, and K. W. Ferrara. An imaging-driven model for liposomal stability and circulation. Mol. Pharm. 7:12-21, 2010.
86. Quesson, B., J. A. De Zwart, and C. T. W. Moonen. Magnetic resonance temperature imaging for guidance of thermotherapy. J. Magn. Reson. Imaging 12:525-533, 2000.
87. Reddick, W. E., R. Bhargava, J. S. Taylor, W. H. Meyer, and B. D. Fletcher. Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy. J. Magn. Reson. Imaging 5:689-694, 1995.
88. Rieke, V., and K. Butts Pauly. MR thermometry. J. Magn. Reson. Imaging 27:376-390, 2008.
89. Roemer, R. B. Engineering aspects of hyperthermia therapy. Annu. Rev. Biomed. Eng. 1:347-376, 1999.
90. Rossin, R., D. Pan, K. Qi, J. L. Turner, X. Sun, K. L. Wooley, and M. J. Welch. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. J. Nucl. Med. 46:1210-1218, 2005.
91. Rybak, J., E. Trachsel, J. Scheuermann, and D. Neri. Ligand-based vascular targeting of disease. ChemMed-Chem 2:22-40, 2007.
92. Rygh, C. B., S. Qin, J. W. Seo, L. M. Mahakian, H. Zhang, R. Adamson, J. Q. Chen, A. D. Borowsky, R. D. Cardiff, R. K. Reed, F. R. Curry, and K. W. Ferrara. Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET. Clin. Cancer Res. 17:550-559, 2011.
93. Schoonooghe, S., D. Laoui, J. A. Van Ginderachter, N. Devoogdt, T. Lahoutte, P. De Baetselier, and G. Raes. Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer. Immunobiology 217:1266-1272, 2012.
94. Sedlacek, H. H., G. Seeman, D. Hoffman, L. P. Czech, C. Kolar, and K. Bossler. Antibodies as carriers of cytotoxicity. In: Contributions to Oncology, 1st edn, edited by H. H. Sedlacek et al. New York: S. Karger Publishing, 1992, pp. 74-75.
95. Seo, J. W., L. M. Mahakian, A. Kheirolomoom, H. Zhang, C. F. Meares, R. Ferdani, C. J. Anderson, and K. W. Ferrara. Liposomal Cu-64 labeling method using bifunctional chelators: poly (ethylene glycol) spacer and chelator effects. Bioconjug. Chem. 21:1206-1215, 2010.
96. Seo, J. W., H. Zhang, D. Kukis, C. Meares, and K. Ferrara. A novel method to label preformed liposomes with Cu-64 for positron emission tomography (PET) imaging. Bioconjug. Chem. 19:2577-2584, 2008.
97. Shokeen, M., and C. J. Anderson. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). Acc. Chem. Res. 42:832-841, 2009.
98. Shokeen, M., A. Zheleznyak, J. M. Wilson, M. Jiang, R. Liu, R. Ferdani, K. S. Lam, J. K. Schwarz, and C. J. Anderson. Molecular imaging of very late antigen-4 (alpha4beta1 integrin) in the premetastatic niche. J. Nucl. Med. 53:779-786, 2012.
99. Smith, S. V. Molecular imaging with copper-64. J. Inorg. Biochem. 98:1874-1901, 2004.
100. 89Zr-labeled human anti-CD147 monoclonal antibody as a positron emission tomography probe in a mouse model of pancreatic cancer. PLoS ONE 8:e61230, 2013.
101. Sundstrøm, T., I. Daphu, I. Wendelbo, E. Hodneland, A. Lundervold, H. Immervoll, K. O. Skaftnesmo, M. Babic, P. Jendelova, E. Sykova, M. Lund-Johansen, R. Bjerkvig, and F. Thorsen. Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. Cancer Res. 73:2445-2456, 2013.
102. Taxt, T., R. Jirik, C. B. Rygh, R. Gruner, M. Bartos, E. Andersen, F. R. Curry, and R. K. Reed. Single-channel blind estimation of arterial input function and tissue impulse response in DCE-MRI. IEEE Trans. Biomed. Eng. 59(4):1012-1021, 2012.
103. Taylor, J. S., and W. E. Reddick. Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. Adv. Drug Deliv. Rev. 41:91-110, 2000.
104. Terreno, E., D. D. Castelli, E. Violante, H. M. H. F. Sanders, N. A. J. M. Sommerdijk, and S. Aime. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer. Chemistry 15:1440-1448, 2009.
105. Thaxton, C. S., D. G. Georganopoulou, and C. A. Mirkin. Gold nanoparticle probes for the detection of nucleic acid targets. Clin. Chim. Acta 363:120-126, 2006.
106. Tofts, P. S., G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. Knopp, H. B. W. Larsson, T. Y. Lee, N. A. Mayr, G. J. M. Parker, R. E. Port, J. Taylor, and R. M. Weisskoff. Estimating kinetic parameters from dynamic contrast-enhanced T (1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10:223-232, 1999.
107. Tofts, P. S., and A. G. Kermode. Measurement of the blood-brain-barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental-concepts. Magn. Reson. Med. 17:357-367, 1991.
108. Tomasi, G., F. Turkheimer, and E. Aboagye. Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future. Mol. Imaging Biol. 14:131-146, 2012.
109. Tousoulis, D., C. Antoniades, N. Koumallos, K. Marinou, E. Stefanadi, G. Latsios, and C. Stefanadis. Novel therapies targeting vascular endothelium. Endothelium 13:411-421, 2006.
110. Vallabhajosula, S. F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin. Nucl. Med. 37:400-419, 2007.
111. Viglianti, B. L., S. A. Abraham, C. R. Michelich, P. S. Yarmolenko, J. R. MacFall, M. B. Bally, and M. W. Dewhirst. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn. Reson. Med. 51:1153-1162, 2004.
112. 89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals. Curr. Top. Med. Chem. 13:446-457, 2013.
113. Wadas, T. J., and C. J. Anderson. Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64. Nat. Protoc. 1:3062-3068, 2006.
114. Wadas, T. J., E. H. Wong, G. R. Weisman, and C. J. Anderson. Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr. Pharm. Des. 13:3-16, 2007.
115. Wall, P. D., W. J. Fry, R. Stephens, D. Tucker, and J. Y. Lettvin. Changes produced in the central nervous system by ultrasound. Science 114:686-687, 1951.
116. Wang, Y. X. Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med. Surg. 1:35-40, 2011.
117. Wang, Y. F., P. F. Liu, L. H. Qiu, Y. Sun, M. J. Zhu, L. Y. Gu, W. Di, and Y. R. Duan. Toxicity and therapy of cisplatin-loaded EGF modified mPEG-PLGA-PLL nanoparticles for SKOV3 cancer in mice. Biomaterials 34:4068-4077, 2013.
118. Wang, Z. X., and L. N. Ma. Gold nanoparticle probes. Coord. Chem. Rev. 253:1607-1618, 2009.
119. Wang, S., I. S. Shin, H. Hancock, B.-S. Jang, H.-S. Kim, S. M. Lee, V. Zderic, V. Frenkel, I. Pastan, C. H. Paik, and M. R. Dreher. Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors. J. Controlled Release 162:218-224, 2012.
120. Watson, K. D., C. Y. Lai, S. Qin, D. E. Kruse, Y. C. Lin, J. W. Seo, R. D. Cardiff, L. M. Mahakian, J. Beegle, E. S. Inghanm, F. R. Curry, R. K. Reed, and K. W. Ferrara. Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors. Cancer Res. 72:1485-1493, 2012.
121. Weber, W. A. Use of PET for monitoring cancer therapy and for predicting outcome. J. Nucl. Med. 46:983-995, 2005.
122. Wei, T., J. Liu, H. Ma, Q. Cheng, Y. Huang, J. Zhao, S. Huo, X. Xue, Z. Liang, and X. J. Liang. Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo. Nano Lett. 13:2528-2534, 2013.
123. Weinmann, H. J., M. Laniado, and W. Mutzel. Pharmacokinetics of GdDTPA dimeglumine after intravenousinjection into healthy-volunteers. Physiol. Chem. Phys. 16:167-172, 1984.
124. 18F] radiolabeled peptides for positron emission tomography. Appl. Radiat. Isot. 70:2720-2729, 2012.
125. 18F-FDG in a murine model of mammary carcinoma. Am. J. Nucl. Med. Mol. Imaging 3:32-43, 2013.
126. Wood, B. J., R. T. Poon, J. K. Locklin, M. R. Dreher, K. K. Ng, M. Eugeni, G. Seidel, S. Dromi, Z. Neennan, M. Kolf, C. D. V. Black, R. Prabhakar, and S. K. Libutti. Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J. Vasc. Interv. Radiol. 23:248-255, 2012.
127. 67Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents. Nucl. Med. Biol. 20:149-155, 1993.
128. Xiao, Y., H. Hong, A. Javadi, J. W. Engle, W. Xu, Y. Yang, Y. Zhang, T. E. Barnhart, W. Cai, and S. Gong. Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. Biomaterials 33:3071-3082, 2012.
129. Xu, W., I. A. Siddiqui, M. Nihal, S. Pilla, K. Rosenthal, H. Mukhtar, and S. Gong. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials 34:5244-5253, 2013.
130. http://www.traxtal.com.
131. Yap, J. T., J. P. J. Carney, N. C. Hall, and D. W. Townsend. Image-guided cancer therapy using PET/CT. Cancer J. 10:221-233, 2004.
132. Yhee, J., S. Kim, H. Koo, S. Son, J. Ryu, I. Youn, K. Choi, I. Kwon, and K. Kim. Optical imaging of cancerrelated proteases using near-infrared fluorescence matrix metalloproteinase-sensitive and cathepsin B-sensitive probes. Theranostics 2:179-189, 2012.
133. Zhang, Y., H. Hong, and W. Cai. PET tracers based on Zirconium-89. Curr. Radiopharm. 4:131-139, 2011.
134. Zhang, H., J. Kusunose, A. Kheirolomoom, J. W. Seo, J. Qi, K. D. Watson, H. A. Lindfors, E. Ruoslahti, J. L. Sutcliffe, and K. W. Ferrara. Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model. Biomaterials 29:1976-1988, 2008.
135. Zhang, H., N. Li, P. Sirish, L. Mahakian, E. Ingham, F. R. Curry, S. Yamada, N. Chiamvimonvat, and K. W. Ferrara. The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium. J. Controlled Release 163:10-17, 2012.
136. Zhang, X. X., Z. Sun, J. Guo, Z. Wang, C. Wu, G. Niu, Y. Ma, D. O. Kiesewetter, and X. Chen. Comparison of F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression. Mol. Imaging Biol. 2013, in press.